JCN Newswire
Read More

Mitsubishi Shipbuilding and NYK Line Obtain Approval in Principle (AiP) from Classification Society ClassNK for Large LCO2 Carrier

ruth
4 minutes

TOKYO, May 16, 2022 - (JCN Newswire via SEAPRWire.com) - Mitsubishi Shipbuilding, a part of Mitsubishi Heavy Industries (MHI) Group, and Nippon Yusen Kabushiki Kaisha (NYK Line) have been granted Approval in Principle (AiP)(Note) from the Japanese classification society ClassNK for joint development of CO2 transport technology for liquefied CO2 (LCO2) carriers.Image of an LCO2 carrierLCO2 carriers transport liquefied CO2 at low temperature and high pressure, which is contained in the cargo tank system. Since the design of cargo containment system depend strongly on the condition of liquefied CO2 such as their temperature and pressure, it is an important technical development issue to increase the size of cargo tank systems and hulls for future mass transportation.In the joint development of LCO2 carriers by Mitsubishi Shipbuilding and NYK Line, which is so performed as to resolve such technical issues, the feasibility and compliance with regulations and standards were confirmed for each cargo tank system and hull section, taking into account different tank pressure settings for medium and large vessels, leading to the grant of the AiP.MHI Group is strategically working to strengthe...

SeaPRwire
Read More

Elevating Australia’s Scientific Acumen: Large Molecule Facility Doubles Size of Australia’s Top Bioanalytical Laboratory

pandora
4 minutes

Thebarton, Australia, May 12, 2022 – (NovationWire) – Agilex Biolabs Pty Ltd has unveiled its new building with a ribbon cutting ceremony by The Honourable Stephen Patterson MP Minister for Trade and Investment at 12:30pm on Thursday 17 February 2022 at 31 Dalgleish street Thebarton South Australia 5031. Agilex Biolabs launched its new laboratory for the analysis of large molecule therapeutics, more than doubling the geographic area of its Adelaide campus. The addition of this 2,520 m2 facility expands the service capabilities of Australia’s most technologically advanced bioanalytical partner and brings a new point of pride to South Australia. State-of-the-art instrument platforms and increased capacity empower drug sponsors from all over the world to succeed as they expand into the novel, promising world of large molecule therapeutics. Areas of medicine such as oncology are seeing new ways of approaching treatment due to innovative modalities like antibody-drug conjugates (ADCs) and allogeneic cell therapies. Gene therapies and vaccines created using genetic platforms such as RNA, miRNA, and siRNA need specialised tools and technology to measure critical safety and efficacy endpoi...

SeaPRwire

US stocks end mostly higher, shrugging off early weakness

elean
2 minutes

NEW YORK (AFP) - Wall Street stocks shrugged off early weakness and finished mostly higher Monday (Aug 16) setting fresh records ahead of earnings reports from large US retailers and key economic releases. Major indices opened the session solidly lower, weighed down by disappointing Chinese economic data and rising expectations that the Federal Reserve will soon announce the phaseout of stimulus measures. But equities shrugged off the early losses, with bargain hunters stepping up purchases as the session progressed. The Dow Jones Industrial Average ended at 35,625.40, up 0.3 per cent to close at a fifth straight record, finishing nearly 400 points above its low earlier in the day. The broad-based S&P 500 gained 0.3 per cent to 4,479.70, also ending with a fifth straight record. But the tech-rich Nasdaq Composite Index declined 0.2 per cent to 14,793.76. This week's calendar features earnings from large retailers including Walmart and Home Depot, as well as US data on July retail sales and housing starts. The schedule also includes the release of minutes from the Fed's July policy meeting which could provide further insight on tapering the central bank's massive bond-buying program...